TIMELINE
- Sep 2023MOTS-c placed in Category 2.
- 23–24 Jul 2026PCAC recommends MOTS-c for the 503A bulks list, 7 to 5.
A small field built on peptides encoded in the mitochondrial genome. Most evidence is from animals and from measurements of circulating levels in people; regulatory interest arrived before clinical trials did.